Varaprasad Reddy
Biotechnology
DiabetOmics
United States of America
Biography
Mr. Varaprasad Reddy has served as a member of our board since 2015. In 1993, Mr. Reddy founded Shantha Biotech to develop and produce recombinant-based vaccines and therapeutic proteins aimed at producing cost-effective drugs and developed first genetically engineered vaccine against Hepatitis-B. Santha Biotech became the world leader in low-cost vaccine delivery to low and middle-income countries. Santha Biotech was acquired by Sanofi. Mr. Reddy is a Padma Bhushan, an award of high honor from the Govt. of India. Mr. Reddy earned an Electronics Engineering degree from Andhra University of India, and an MBA from Osmania University.
Research Interest
biotechnology